Your browser doesn't support javascript.
loading
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.
Bomben, Riccardo; Rossi, Francesca Maria; Vit, Filippo; Bittolo, Tamara; Zucchetto, Antonella; Papotti, Robel; Tissino, Erika; Pozzo, Federico; Degan, Massimo; Polesel, Jerry; Bulian, Pietro; Marasca, Roberto; Reda, Gianluigi; Laurenti, Luca; Olivieri, Jacopo; Chiarenza, Annalisa; Laureana, Roberta; Postorino, Massimiliano; Del Principe, Maria Ilaria; Cuneo, Antonio; Gentile, Massimo; Morabito, Fortunato; Fronza, Gilberto; Tafuri, Agostino; Zaja, Francesco; Foà, Robin; Di Raimondo, Francesco; Del Poeta, Giovanni; Gattei, Valter.
Afiliação
  • Bomben R; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. rbomben@cro.it.
  • Rossi FM; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Vit F; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Bittolo T; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Zucchetto A; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Papotti R; International PhD School in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Tissino E; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Pozzo F; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Degan M; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Polesel J; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Bulian P; Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Marasca R; Clinical and Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Reda G; Hematology Unit, Department of Oncology and Hematology, Azienda-Ospedaliero Universitaria (AOU) of Modena, Policlinico, Modena, Italy.
  • Laurenti L; Department of Medical and Surgical Sciences, University of Modena e Reggio Emilia, Modena, Italy.
  • Olivieri J; Division of Ematologia, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
  • Chiarenza A; Fondazione Universitaria Policlinico A Gemelli di Roma, Roma, Italy.
  • Laureana R; Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi" DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy.
  • Postorino M; Division of Hematology, Policlinico, Department of Surgery and Medical Specialties, University of Catania, Catania, Italy.
  • Del Principe MI; Division of Haematology, University of Tor Vergata, Rome, Italy.
  • Cuneo A; Division of Haematology, University of Tor Vergata, Rome, Italy.
  • Gentile M; Division of Haematology, University of Tor Vergata, Rome, Italy.
  • Morabito F; Hematology Section, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Fronza G; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Tafuri A; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.
  • Zaja F; Hematology Unit AO of Cosenza, Cosenza, Italy.
  • Foà R; Hematology Oncology Department, Augusta Victoria Hospital, East Jerusalem, Israel.
  • Di Raimondo F; Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Del Poeta G; Department of Clinical and Molecular Medicine and Hematology, Sant'Andrea - University Hospital - Sapienza, University of Rome, Rome, Italy.
  • Gattei V; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Leukemia ; 37(4): 914-918, 2023 04.
Article em En | MEDLINE | ID: mdl-36807650
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article